Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of eravacycline versus ertapenem for complicated intra-abdominal infections
ChiCTR1900022060Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eravacycline and ertapenem in Intra-abdominal infection (IAI) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Clinical efficacy. Started Apr 2019; status: completed.
02
Drugs
eravacyclineertapenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on ChiCTR1900022060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022060.